VBI Historical Income Statement
| VBIV Stock | USD 0.59 0.02 3.28% |
Historical analysis of VBI Vaccines income statement accounts such as Interest Expense of 8.5 M, Selling General Administrative of 44.3 M, Total Revenue of 9.1 M or Other Operating Expenses of 67.2 M can show how well VBI Vaccines performed in making a profits. Evaluating VBI Vaccines income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of VBI Vaccines's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining VBI Vaccines latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether VBI Vaccines is a good buy for the upcoming year.
VBI |
About VBI Income Statement Analysis
VBI Vaccines Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to VBI Vaccines shareholders. The income statement also shows VBI investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
VBI Vaccines Income Statement Chart
VBI Vaccines Income Statement is one of the three primary financial statements used for reporting VBI's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of VBI Vaccines revenue and expense. VBI Vaccines Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, VBI Vaccines' Research Development is fairly stable compared to the past year. Interest Income is likely to climb to about 2.1 M in 2024, despite the fact that Operating Income is likely to grow to (52.5 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of VBI Vaccines. It is also known as VBI Vaccines overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from VBI Vaccines' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into VBI Vaccines current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.At this time, VBI Vaccines' Research Development is fairly stable compared to the past year. Interest Income is likely to climb to about 2.1 M in 2024, despite the fact that Operating Income is likely to grow to (52.5 M).
| 2023 | 2024 (projected) | Non Recurring | 5.7M | 5.0M | Reconciled Depreciation | 2.0M | 1.6M |
VBI Vaccines income statement Correlations
Click cells to compare fundamentals
VBI Vaccines Account Relationship Matchups
High Positive Relationship
High Negative Relationship
VBI Vaccines income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 2.2M | 2.7M | 4.7M | 4.0M | 8.1M | 8.5M | |
| Selling General Administrative | 14.1M | 20.7M | 38.3M | 56.1M | 42.1M | 44.3M | |
| Total Revenue | 2.2M | 1.1M | 631K | 1.1M | 8.7M | 9.1M | |
| Gross Profit | (5.7M) | (8.1M) | (10.1M) | (10.2M) | (5.8M) | (5.5M) | |
| Other Operating Expenses | 48.3M | 44.7M | 68.7M | 82.9M | 64.0M | 67.2M | |
| Operating Income | (52.4M) | (43.6M) | (68.0M) | (81.8M) | (55.3M) | (52.5M) | |
| Ebit | (52.4M) | (43.6M) | (68.0M) | (81.8M) | (55.3M) | (52.5M) | |
| Ebitda | (46.1M) | (42.0M) | (66.2M) | (79.8M) | (53.3M) | (50.7M) | |
| Total Operating Expenses | 40.4M | 35.5M | 57.9M | 71.6M | 49.5M | 52.0M | |
| Income Before Tax | (54.8M) | (46.2M) | (69.8M) | (113.3M) | (92.8M) | (88.2M) | |
| Total Other Income Expense Net | (2.4M) | (2.6M) | (1.7M) | (31.5M) | (37.5M) | (35.6M) | |
| Net Income | (55.8M) | (47.3M) | (72.7M) | (141.0M) | (92.8M) | (88.2M) | |
| Income Tax Expense | 992K | 1.1M | 2.9M | 27.6M | 31.8M | 33.4M | |
| Depreciation And Amortization | 6.3M | 1.7M | 1.8M | 2.1M | 2.0M | 2.1M | |
| Cost Of Revenue | 7.9M | 9.2M | 10.8M | 11.3M | 14.5M | 15.2M | |
| Net Income From Continuing Ops | (54.8M) | (46.2M) | (69.8M) | (113.3M) | (114.0M) | (108.3M) | |
| Research Development | 26.3M | 14.9M | 19.6M | 15.5M | 9.3M | 15.8M | |
| Net Income Applicable To Common Shares | (54.8M) | (46.2M) | (69.8M) | (113.3M) | (102.0M) | (96.9M) | |
| Interest Income | 835K | 613K | 372K | 1.4M | 2.0M | 2.1M | |
| Net Interest Income | (2.2M) | (2.7M) | (4.7M) | (3.8M) | (5.9M) | (5.6M) | |
| Non Operating Income Net Other | (218K) | 95K | 3.0M | (27.5M) | (24.7M) | (23.5M) | |
| Reconciled Depreciation | 1.2M | 1.7M | 1.8M | 2.1M | 2.0M | 1.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Revenue Per Share 0.558 | Quarterly Revenue Growth 1.911 | Return On Assets (0.29) | Return On Equity (2.59) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.